XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 97,009,000 $ 102,304,000
Short-term investment securities 47,896,000 59,374,000
Accounts receivable, net 17,484,000  
Inventories 30,234,000  
Prepaid research and development 4,863,000 4,237,000
Other current assets 11,088,000 2,359,000
Total current assets 208,574,000 168,274,000
Restricted cash 1,279,000 1,273,000
Long-term investment securities   12,404,000
Right of use assets 8,475,000 8,888,000
Leasehold interest, net 1,521,000 1,627,000
Equipment, net 206,000 307,000
Goodwill 799,000 799,000
Total assets 220,854,000 193,572,000
Current liabilities:    
Accounts payable and accrued expenses 62,945,000 42,019,000
Other current liabilities 1,569,000 1,169,000
Lease liability - current portion 1,512,000 1,581,000
Accrued compensation 6,641,000 8,432,000
Total current liabilities 72,667,000 53,201,000
Deferred revenue, net of current portion 229,000 305,000
Loan payable - non-current 97,700,000 71,135,000
Lease liability - non-current 9,805,000 10,344,000
Total liabilities 180,401,000 134,985,000
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.001 par value per share (175,000,000 shares authorized, 150,969,323 and 146,426,697 shares issued, 150,928,014 and 146,385,388 shares outstanding at June 30, 2023 and December 31, 2022, respectively) 151,000 146,000
Additional paid-in capital 1,654,411,000 1,585,708,000
Treasury stock, at cost, 41,309 shares at June 30, 2023 and December 31, 2022 (234,000) (234,000)
Accumulated deficit (1,613,875,000) (1,527,033,000)
Total stockholders' equity 40,453,000 58,587,000
Total liabilities and stockholders' equity $ 220,854,000 $ 193,572,000